Webinar: Medtech quality and regulatory compliance

This webinar is for you who are developing or planning to develop a medical device, combination, or borderline product. In one hour, we will discuss what you ne...

EU Pharmaceutical Legislation Reform

The EU's Pharmaceutical Legislation Reform, proposed by the commission within the European Health Union, aims to establish a citizen-centric framework to enhanc...

Medicon Village Science Park

Valves with piezo technology

Efficient control and regulation of gases in medical technology

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Noxious parasite forms hybrids and deceives the immune system

The small parasite Trypanosoma cruzi has a nasty ability to cause serious illness. Researchers at the Karolinska Institutet have now mapped its ability to decei...

Stockholm och Uppsala bildar gemensamt life science-kluster

Stockholm och Uppsala stärker samarbetet inom medicinsk forskning och biotech.

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2026)

Pfizer vinner budstriden om fetmauppstickaren Metsera

Pfizer har slutit ett avtal på 10 miljarder dollar, motsvarande 95 miljarder kronor, för att köpa det amerikanska bioteknikbolaget Metsera, efter att Novo Nordi...

Uppsala-based company wins important patent dispute – but the decision is subject to appeal

A US district court has ruled in favour of Orexo in a dispute over the patent protecting the Swedish company’s drug Zubsolv, developed for treating patients wit...

Rapid development in blood analysis – “Sweden is leading the race”

Thousands of analytical tests using just one single drop of blood. What was revealed as a hoax just a few years ago is now a reality, according to KTH professor...

Webinar: Clinical evaluation and clinical investigation of medical devices

Whether you are a small medtech company or a large one, this webinar is a must-attend for anyone curious about how clinical studies on medical devices are conducted.

The Oresund region aims at becoming Europe’s microbiome Mecca

The Medicon Valley Alliance’s ambition: Skåne and the Copenhagen region will become world leaders in microbiome research.

Swedish and Ukrainian Medical Product Agencies sign an agreement

The Directors-General of the Swedish and Ukrainian Medical Products Agencies have signed a cooperation agreement.

Reveal the Structures and Functions of Life

Super-resolution microscopes from ZEISS.

Samuel Lagercrantz: Collaboration and joint efforts are the key to success

Although many questions about Covid-19 remain unanswered, the development of drugs and vaccines has been incredibly rapid, writes Samuel Lagercrantz, Life Scien...

Non-destructive testing and assembly control

Assess complete assembly.

Sparkades som vd för Novo Nordisk – här är Lars Fruergaard Jørgensens nya jobb

Den tidigare Novo Nordisk-vd:n ska stärka Danmarks internationella position som ledande life science-nation.

Cytel Sweden

Elevating 3D characterization with enhanced performance and efficiencies

Introducing the ZEISS VersaXRM 730 3D X-ray microscope.

Nytt bud på vaccinbolaget Bavarian Nordic – ”bästa och slutgiltiga”

Ett konsortium lett av Nordic Capital och Permira höjer sitt bud på vaccintillverkaren Bavarian Nordic. Det nya budet är enligt konsortiet det sista – och komme...

Novo Nordisk to invest billions in Danish manufacturing facilities

Danish pharmaceutical giant Novo Nordisk is investing DKK 42 billion, equivalent to around SEK 65 billion/EUR 5.6 billion, in its manufacturing facilities in Ka...

Roche förvärvar amerikanskt biotechbolag i miljardaffär

Det schweiziska läkemedelsbolaget Roche förvärvar det amerikanska bioteknikbolaget 89bio för upp till 3,5 miljarder dollar, motsvarande närmare 33 miljarder kronor.

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.